Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gastrointestinal stromal tumors: current issues].

Serafina Lattarulo1, Ippazio Ugenti, Filippo Ferrarese

  • 1Sezione di Chirurgia Generale Dipartimento di Scienze Chirurgiche Generali e Specialistiche Università degli Studi di Bari.

Chirurgia Italiana
|May 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low Arrhythmic Risk in Individuals With Brugada ECG Pattern and a Negative dST-Tiso Criterion.

The American journal of cardiology·2026
Same author

Hybrid mini-thoracotomy for Brugada syndrome: epicardial substrate characterization and ablation-results from UNCOVER(BrS) study.

Frontiers in cardiovascular medicine·2025
Same author

Delta-wave automatic mapping of the manifest accessory pathway.

Frontiers in cardiovascular medicine·2024
Same author

Temperature and ST-segment morphology remote monitoring: new perspectives for implantable cardiac monitors in Brugada syndrome.

Pacing and clinical electrophysiology : PACE·2024
Same author

Predicting ventricular arrhythmia inducibility in ajmaline-induced Brugada type I pattern: Validation of the dST-Tiso interval.

Journal of cardiovascular electrophysiology·2024
Same author

Utility of an innovative cloud-based storage software for ablation redo procedures: Initial experience.

Heart rhythm O2·2024

Gastrointestinal stromal tumors (GISTs) are rare digestive tract neoplasms. Immunohistochemistry, particularly CD34 and CD117 expression, is crucial for diagnosing GISTs, guiding patient follow-up.

Area of Science:

  • Gastrointestinal Pathology
  • Surgical Oncology
  • Molecular Diagnostics

Context:

  • Gastrointestinal stromal tumors (GISTs) are rare neoplasms, accounting for <1% of primitive digestive tumors.
  • GISTs originate from connective tissue and are characterized by specific cellular markers.
  • Accurate diagnosis relies on advanced techniques like immunohistochemistry and genetic analysis.

Purpose:

  • To evaluate the histopathological and immunohistochemical findings of submucosal tumors, focusing on GISTs.
  • To confirm the diagnostic utility of specific markers such as CD34 and CD117 in GIST identification.
  • To assess the diagnostic process from initial endoscopic findings to definitive postoperative analysis.

Summary:

  • A study analyzed 11 submucosal tumors, including 8 GISTs, using histopathology and immunohistochemistry.

Related Experiment Videos

  • Constant high positivity for CD34 and CD117 was confirmed in GIST cases.
  • Definitive diagnosis was achieved postoperatively, highlighting the importance of immunohistochemical analysis.

    • Impact:

    • Reinforces the critical role of CD117 (c-kit) and CD34 immunohistochemistry in diagnosing GISTs.
    • Emphasizes the need for regular patient follow-up, even in the absence of adverse prognostic indicators.
    • Contributes to understanding the diagnostic pathway and management of these rare gastrointestinal neoplasms.